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Expanding the use of heat stabilization to blood, metabolites
and pharmaceuticals
Mats Borén
Denator AB, Sweden
The Stabilizor system has traditionally been applied to tis-
sue samples to enable accurate analysis of peptides, proteins
and their modiﬁcations without the risk of change. Recently
the beneﬁts of using enzymatic heat inactivation have been
shown for analysis of metabolites, pharmaceutical as well as
natural using MALDI Imaging [1]. Heat stabilization of phar-
maceutical metabolites has also been shown to be beneﬁcial
in combination with Dried Blood Spots (DBS) sampling. DBS
is a cost effective method to study pharmaceutical turn over
and clearance using small amounts of blood on ﬁlter paper.
A drop of blood is placed on the ﬁlter paper and allowed to
dry. Once dried the paper can be stored a shipped at room
temperature, however drying takes from one hour and longer
depending on humidity. During this time enzymatic activity
in the blood can affect analyte levels in the sample distorting
the original levels. When instead the newly applied blood spot
is inactivated using heat the original levels are preserved and
the analytical results better reﬂect the situation in the body.
In vitro conversion during drying have been shown for several
pharmacuiticals, including Tamiﬂu® and Brevibloc® [2].
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New vertical and horizontal gel-electrophoresis systems and
a novel highly sensitive pre-labelling ﬂuorescent dye for pro-
teins
Reiner Westermeier
SERVA Electrophoresis GmbH, Heidelberg, Germany
For vertical minigel electrophoresis a new system with the
name PRiME has been launched, which consists of a novel
electrophoresis chamber and unique modiﬁed “Laemmli” gels
with long-term stability. The gels show the same separation
parameters as lab-cast Laemmli gels, but run faster and show
superior protein transfer during blotting. Using the classical
glycine running gel buffer, the gradient gels have separation
ranges down to 3kDa.
A new ﬂatbed chamber generation for high resolution iso-
electric focusing and horizontal electrophoresis is introduced.
The new developed Blue Horizon chamber is technically
based on the HPE Tower design and enables 1D and 2D elec-
trophoresis using advanced electrical conditions, which leads
to highest possible resolution and reproducibility. The unit
runs all available precast horizontal gels from SERVA, like the
HPE 2D Gels, the 1D SDS PAGE and Native Gels as well as the
Precotes and Focus gels for IEF.
The ﬂuorescent dye (“SERVA Lightning Red”) for pre-
labelling of protein samples for 1 and 2D electrophoresis
with high detection sensitivitymakes protein detection easier,
faster, and more efﬁcient. The new protein label technology
from SERVA makes ﬂuorescent detection available at low cost!
http://dx.doi.org/10.1016/j.euprot.2013.11.004
2212-9685 & 2013 Published by Elsevier Ltd. Open access under CC BY-NC-ND license.
